Small Boost In Proposed NIH Budget Could Help Fund Electroceuticals Project
This article was originally published in The Gray Sheet
The National Institutes of Health would see only a slight, less than one percent, increase over 2014 in its fiscal year 2015 budget under the president’s spending plan, but part of the increase could advance so-called electroceuticals research, NIH Director Francis Collins explained.
You may also be interested in...
By seeding exploratory lab work across several biomedical and engineering disciplines, pharma giant GlaxoSmithKline wants to understand how neural signals regulate diseases and eventually to design devices that can alter signals and provide therapeutic benefit.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.
The IVDR implementation schedule is problematic. European notified bodies say solutions must be grasped if public health is not to suffer.